A review synthesizes current knowledge on established and novel treatment strategies and highlights gaps in research and treatment.
Obesity rates have increased dramatically over the past 3 decades, with adolescent obesity often transitioning to adult obesity. During adolescence, obesity can adversely affect both growth and development.
A recent review provides a comprehensive overview of the evidence for behavioral, medical (pharmacologic), device, and surgical interventions for adolescents (ages 11 to 21) who are obese or at risk for obesity, while pointing out their overall lack of effectiveness in stemming the adolescent obesity epidemic. The authors highlight methodological concerns, including inconsistency in measurement. For example, the terms “overweight” and “obesity” have varied in their definitions, complicating the study of associated disease risk, morbidity,…
Author
DisclosuresConsultant/Advisory BoardEli Lilly and Company; Advisory Council, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Subboard for Adolescent Medicine, American Board of Pediatrics
Grant/Research SupportPatty Brisben Foundation
Editorial BoardsOsteoporosis International; Bone; Journal of Adolescent Health
DisclosuresConsultant/Advisory BoardEli Lilly and Company; Advisory Council, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Subboard for Adolescent Medicine, American Board of Pediatrics
Grant/Research SupportPatty Brisben Foundation
Editorial BoardsOsteoporosis International; Bone; Journal of Adolescent Health